Adalta Ltd (1AD)

Currency in AUD
0.002
0.000(0.00%)
Closed·
1AD Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
1AD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0020.002
52 wk Range
0.0020.021
Key Statistics
Bid/Ask
0.002 / 0.003
Prev. Close
0.002
Open
0.002
Day's Range
0.002-0.002
52 wk Range
0.002-0.021
Volume
2.08K
Average Volume (3m)
8.79M
1-Year Change
-88.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1AD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Adalta Ltd Company Profile

AdAlta Limited, a clinical-stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. It has discovered WD-34 for the multiple malaria species, Babesia, and Toxoplasma in collaboration with La Trobe University. The company was incorporated in 2006 and is based in Camberwell, Australia.

Compare 1AD to Peers and Sector

Metrics to compare
1AD
Peers
Sector
Relationship
P/E Ratio
−0.5x−4.6x−0.7x
PEG Ratio
−0.01−0.090.00
Price/Book
−3.9x3.8x2.6x
Price / LTM Sales
3.4x11.3x3.4x
Upside (Analyst Target)
-194.6%35.7%
Fair Value Upside
Unlock0.9%4.1%Unlock

Earnings

Latest Release
Aug 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
301.92K / --
EPS Revisions
Last 90 days

1AD Income Statement

People Also Watch

0.006
AVE
0.00%
2.920
MSB
+9.36%
0.032
SNT
-5.88%
2.930
SIG
+1.03%

FAQ

What Stock Exchange Does Adalta Trade On?

Adalta is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Adalta?

The stock symbol for Adalta is "1AD."

What Is the Adalta Market Cap?

As of today, Adalta market cap is 2.31M.

What Is Adalta's Earnings Per Share (TTM)?

The Adalta EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is 1AD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Adalta Stock Split?

Adalta has split 3 times.

How Many Employees Does Adalta Have?

Adalta has 0 employees.

What is the current trading status of Adalta (1AD)?

As of 08 Oct 2025, Adalta (1AD) is trading at a price of 0.002, with a previous close of 0.00. The stock has fluctuated within a day range of 0.002 to 0.002, while its 52-week range spans from 0.002 to 0.021.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.